GISEV Family Office
Europe, Ticino, Switzerland, Lugano
Description
GISEV Family Office is a investment firm.
Investor Profile
GISEV Family Office has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Argentina.
- Strong thematic focus on Health Care, Biotechnology, Therapeutics.
Stage Focus
- Series A (38%)
- Seed (13%)
- Series Unknown (13%)
- Series B (13%)
- Pre Seed (13%)
- Series C (13%)
Country Focus
- United States (75%)
- United Kingdom (13%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Argentina (13%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(45 400 250)'/%3e%3cuse xlink:href='%23a' transform='rotate(67.5 400 250)'/%3e%3cpath id='b' fill='%2385340a' d='M404.31 274.41c.453 9.054 5.587 13.063 4.579 21.314 2.213-6.525-3.124-11.583-2.82-21.22m-7.649-23.757 19.487 42.577-16.329-43.887'/%3e%3cuse xlink:href='%23b' transform='rotate(22.5 400 250)'/%3e%3cuse xlink:href='%23b' transform='rotate(45 400 250)'/%3e%3cuse xlink:href='%23b' transform='rotate(67.5 400 250)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='rotate(90 400 250)'/%3e%3cuse xlink:href='%23c' transform='rotate(180 400 250)'/%3e%3cuse xlink:href='%23c' transform='rotate(270 400 250)'/%3e%3ccircle cx='400' cy='250' r='27.778' fill='%23f6b40e' stroke='%2385340a' stroke-width='1.5'/%3e%3cpath id='h' fill='%23843511' d='M409.47 244.06c-1.897 0-3.713.822-4.781 2.531 2.136 1.923 6.856 2.132 10.062-.219a7.333 7.333 0 0 0-5.281-2.312zm-.031.438c1.846-.034 3.571.814 3.812 1.656-2.136 2.35-5.55 2.146-7.687.437.935-1.495 2.439-2.067 3.875-2.094z'/%3e%3cuse xlink:href='%23d' transform='matrix(-1 0 0 1 800.25 0)'/%3e%3cuse xlink:href='%23e' transform='matrix(-1 0 0 1 800.25 0)'/%3e%3cuse xlink:href='%23f' transform='translate(18.862)'/%3e%3cuse xlink:href='%23g' transform='matrix(-1 0 0 1 800.25 0)'/%3e%3cpath fill='%2385340a' d='M395.75 253.84c-.913.167-1.563.977-1.563 1.906 0 1.062.878 1.906 1.938 1.906a1.89 1.89 0 0 0 1.563-.812c.739.556 1.764.615 2.312.625.084.002.193 0 .25 0 .548-.01 1.573-.069 2.313-.625.36.516.935.812 1.562.812 1.06 0 1.938-.844 1.938-1.906 0-.929-.65-1.74-1.563-1.906.513.18.844.676.844 1.219a1.28 1.28 0 0 1-1.281 1.281c-.68 0-1.242-.54-1.282-1.219-.208.417-1.034 1.655-2.656 1.719-1.622-.064-2.447-1.302-2.656-1.719-.04.679-.6 1.219-1.281 1.219a1.28 1.28 0 0 1-1.281-1.281c0-.542.33-1.038.843-1.219zm2.09 5.69c-2.138 0-2.983 1.937-4.906 3.219 1.068-.427 1.91-1.27 3.406-2.125 1.496-.855 2.772.187 3.625.187h.031c.853 0 2.13-1.041 3.625-.187 1.497.856 2.369 1.698 3.438 2.125-1.924-1.282-2.8-3.219-4.938-3.219-.426 0-1.271.23-2.125.656h-.031c-.853-.426-1.698-.656-2.125-.656z'/%3e%3cpath fill='%2385340a' d='M397.12 262.06c-.844.037-1.96.207-3.563.688 3.848-.855 4.697.437 6.407.437h.03c1.71 0 2.56-1.292 6.407-.438-4.274-1.282-5.124-.437-6.406-.437h-.031c-.802 0-1.437-.312-2.844-.25z'/%3e%3cpath fill='%2385340a' d='M393.75 262.72c-.248.003-.519.005-.813.031 4.488.428 2.331 3 7.032 3h.03c4.702 0 2.575-2.572 7.063-3-4.7-.426-3.214 2.344-7.062 2.344h-.031c-3.608 0-2.496-2.421-6.22-2.375zm10.1 6.94a3.848 3.848 0 0 0-3.846-3.846 3.848 3.848 0 0 0-3.847 3.846 3.955 3.955 0 0 1 3.847-3.04 3.952 3.952 0 0 1 3.846 3.04z'/%3e%3cpath id='e' fill='%2385340a' d='M382.73 244.02c4.915-4.273 11.11-4.915 14.53-1.709.837 1.121 1.373 2.32 1.593 3.57.43 2.433-.33 5.062-2.236 7.756.215-.001.643.212.856.427 1.697-3.244 2.297-6.577 1.74-9.746a13.815 13.815 0 0 0-.67-2.436c-4.7-3.845-11.11-4.272-15.81 2.138z'/%3e%3cpath id='d' fill='%2385340a' d='M390.42 242.74c2.777 0 3.419.642 4.7 1.71 1.284 1.068 1.924.854 2.137 1.068.213.215 0 .854-.426.64s-1.284-.64-2.564-1.708c-1.283-1.07-2.563-1.069-3.846-1.069-3.846 0-5.983 3.205-6.41 2.991-.426-.214 2.137-3.632 6.41-3.632z'/%3e%3cuse xlink:href='%23h' transform='translate(-19.181)'/%3e%3ccircle id='f' cx='390.54' cy='246.15' r='1.923' fill='%2385340a'/%3e%3cpath id='g' fill='%2385340a' d='M385.29 247.44c3.633 2.778 7.265 2.564 9.402 1.282 2.136-1.282 2.136-1.709 1.71-1.709-.427 0-.853.427-2.564 1.281-1.71.856-4.273.856-8.546-.854z'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Wellness
- Personal Health
- Beauty
- Health Diagnostics
- Natural Resources
- Biopharma
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does GISEV Family Office frequently co-invest with?
Which angels does GISEV Family Office often collaborate with?
What are some of recent deals done by GISEV Family Office?
Find More Investors Like GISEV Family Office
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
